This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Cryoinfra, Infra fined $14.8 million in Mexican probe into oxygen, nitrogen, argon markets

( September 14, 2022, 20:08 GMT | Official Statement) -- MLex Summary: Cryoinfra and Infra have been fined a total of 296.3 Mexican pesos ($14.8 million) by the national competition authority for failing to comply with commitments to improve competition in the markets for the sale and distribution of oxygen, nitrogen and argon, according to a statement. The Federal Economic Competition Commission, or Cofece, started investigating the case in 2014, following a complaint related to alleged discriminatory practices carried out by several companies in those markets. In 2018, Infra and Cryoinfra requested the early ruling of the case, where they offered measures to settle the investigation, including eliminating exclusivity clauses in existing business contracts.Cofece press release follows below in Spanish:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections